Presentations
Presentations from Neola Medical
Neola Medical participates in several capital market days and other investor meetings.
Below we collect recordings from stock market days and other occasions. The presentations are held in Swedish or English.
Presentation about Neola Medical at ABGSC Investor Day in December 2022
Neola Medical’s CEO Hanna Sjöström presented about the company at ABGSC Investor Day in Stockholm the 6th of December. In the presentation, Hanna talks more about the company, the recent preferential rights issue, the company’s certification according to ISO 13485,...
Presentation about Neola Medical at BioStock Life Science Fall Summit 2022
The 29th–30th of November, BioStock Life Science Fall Summit 2022 was arranged at Medicon Village in Lund. During the event, Neola Medical’s CEO Hanna Sjöström presented about the company, the latest development, and upcoming milestones. Read more about the...
CEO Hanna Sjöström presenting the company in Aktieportföljen Live
The 11th of October CEO Hanna Sjostrom presented about the company and the rights issue in Aktieportföljen Live. In the presentation Hanna told more about the company and the medicine technology device Neola®, but also about the current rights issue and upcoming...
Neola Medical presenting in Aktieportföljen Live
Tuesday the 11th of October it is time for Aktieportföljen Live from Stockholm, and at 1.35-2.05pm CET (13.35-14.05) CEO Hanna Sjöström will present about Neola Medical. In the presentation she will tell more about the company and the medicine technology device...
CEO Hanna Sjöström presents rights issue
CEO Hanna Sjöström presented in beginning of October in Direct Studios about the company, milestones and the ongoing rights issue. After the presentation a shorter Q&A was led by Mattias Vahlne from Direkt Studios. See the presentation here:...
CEO Hanna Sjöström in BioStock Investor Pitch
Tuesday the 4th of October, our CEO Hanna Sjöström presented at BioStock Investor Pitch. In the presentation our CEO presents about the company's milestones and the Rights Issue. After the presentation there is a shorter Q&A with Olivia Samuelsson from...
Interview with CEO Hanna Sjöström about the clinical study and the rights issue
BioStock have interviewed CEO Hanna Sjöström to get to know more about the ongoing clinical study with the Neola®-device at University College Cork, Ireland, where the recruitment of 100 babies is completed. In the interview, the upcoming rights issue is also...
Presentation at ABG Sundal Collier’s Investor Day 2022
Neola Medical's CEO Hanna Sjöström presented the company at ABG Sundal Collier's Investor Day yesterday the 13th of September 2022. See previous press communication about the participation. See the presentation online here....
CEO and CFO presents Q2 report for 2022
CEO Hanna Sjöström and CFO Christian Gyllenberg presents the Q2 report for 2022 and answer questions in the following Q&A. https://youtu.be/zJ3Q6aT2Fsc
Analyst Group has published a new analysis of Neola Medical
In the latest analysis of Neola Medical, Analyst Group writes that the company is moving in the right direction despite prevailing macroeconomic conditions. “We see that Neola Medical is going in the right direction, but simultaneously, the macroeconomic...
